Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,113

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,793

Class I recallsReasonable probability of serious health consequences

24,343

Class II recallsTemporary or medically reversible health consequences

2,887

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,072 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/whole-foods-market-issues-allergy-alert-undeclared-egg-cabricharme-cheesePublished September 11, 2026

Most affected stateHawaii 200 recalls mention this state

State: AS ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated September 15, 2026 ET

Summary (Year to date)

1,527 recalls have been announced year to date.
Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
The highest complete period was Jun 2026 (297).
Sep 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,343
Class I	9,793
Class III	2,887
Not Yet Classified	1

Download CSV

Recalls by class
Class	Recalls
Class II	24,343
Class I	9,793
Class III	2,887
Not Yet Classified	1

FDA Recall United States Terminated Historical recordClass II

EAGLE FAMILY FOODS GROUP LLC

Product: 365 Everyday Value Organic Classic Salted Popcorn, 6 oz. bag…
Reason: Foreign material, pieces of glass may be in the product
Published: October 7, 2020
Distribution: Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

EAGLE FAMILY FOODS GROUP LLC

Product: 365 Whole Foods Market Organic Reduced fat &Sodium Popcorn,…
Reason: Foreign material, pieces of glass may be in the product
Published: October 7, 2020
Distribution: Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

EAGLE FAMILY FOODS GROUP LLC

Product: 365 Whole Foods Market Organic White Cheddar Popcorn, 4 oz.…
Reason: Foreign material, pieces of glass may be in the product
Published: October 7, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Red-E Tablet, Proprietary Blend 3000 mg**, packaged in 1-count plastic bag stapled with cardboard labeling.

by The Protein Shoppe

Reason: Marketed Without An Approved NDA/ANDA: product found to be tainted with sildenafil, an FDA approved drug for the treatment of male erectile dysfunction, making this an unapproved drug fro which the safety and efficacy have not been established and therefore subject to recall.
Published: September 30, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Albuterol Sulfate Inhalation Aerosol, 90 mcg per actuation, 200 metered inhalations, Manufactured by: Catalent Pharma Solutions, 160 N Pharma Drive, Morrisville, NC 27560, Distributed by: Perrigo, Allegan, MI 49010 NDC 45802-088-01

by Perrigo Company PLC

Reason: Defective Delivery System: Sustained trend of failure to dispense complaints.
Published: September 30, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Nature Throid, 1.5 Grain (97.5 mg) Thyroid USP [Liothyronine (T3) 13.5 mcg, Levothyroxine (T4) 57 mcg], packaged in a) 30-count bottles (NDC 64727-3305-4), b) 60-count bottles (NDC 64727-3305-5), c) 90-count bottles (NDC 64727-3305-6), and 100-count bottles (NDC 64727-3305-1), Rx only, Manufactured by: RLC Labs Phoenix, AZ 85024, NDC 64727-3305-1

by RLC Labs Inc.

Reason: Subpotent Drug: FDA analysis found product to be subpotent
Published: September 23, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Nature Throid, 2 Grain (130 mg) Thyroid USP [Liothyronine (T3) 18 mcg, Levothyroxine (T4) 76 mcg], packaged in a) 30-count bottles (NDC 64727-3308-4) and b)100-count bottles (NDC 64727-3308-1), Rx only, Manufactured by: RLC Labs Phoenix, AZ 85024

by RLC Labs Inc.

Reason: Subpotent Drug: FDA analysis found product to be subpotent
Published: September 23, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Nature Throid, 1.25 Grain (81.25 mg) Thyroid USP [Liothyronine (T3) 11.25 mcg, Levothyroxine (T4) 47.5 mcg], 100-count bottles, Rx only, Manufactured by: RLC Labs Phoenix, AZ 85024, NDC 64727-3303-1

by RLC Labs Inc.

Reason: Subpotent Drug: FDA analysis found product to be subpotent
Published: September 23, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Nature Throid, 3/4 Grain (48.75 mg) Thyroid USP [Liothyronine (T3) 6.75 mcg, Levothyroxine (T4) 28.5 mcg], packaged in a) 100-count bottles (NDC 64727-3302-1) and b) 1000-count bottles (NDC 64727-3302-2), Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034

by RLC Labs Inc.

Reason: Subpotent Drug: FDA analysis found product to be subpotent
Published: September 23, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Nature Throid, 1/2 Grain (32.5 mg) Thyroid USP [Liothyronine (T3) 4.5 mcg, Levothyroxine (T4) 19 mcg], packaged in a) 90-count bottles (NDC 64727-3299-6), b) 100-count bottles (NDC 64727-3299-1), Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034

by RLC Labs Inc.

Reason: Subpotent Drug: FDA analysis found product to be subpotent
Published: September 23, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

WP Thyroid, Westhroid Pure, 1/2 Grain (32.5 mg) Thyroid USP [Liothyronine (T3) 4.5 mcg, Levothyroxine (T4) 19 mcg], packaged in a) 30-count bottles (NDC 64727-5550-4), b) 90-count bottles (NDC 64727-5550-6), c) 100-count bottles (NDC 64727-5550-1), Rx only, Manufactured by: RLC Labs Phoenix, AZ 85024

by RLC Labs Inc.

Reason: Subpotent Drug: FDA analysis found product to be subpotent
Published: September 23, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

WP Thyroid, Westhroid Pure, 2 Grain (130 mg) Thyroid USP packaged in a) 1,000 Tablets, NDC 64727-5950-2 ; b) 30 Tablets, NDC 64727-5950-4; c) 60 Tablets, NDC 64727-5950-5; d) 90 Tablets, NDC 64727-5950-6; e) 100 Tablets, NDC 64727-5950-1; Rx Only, Manufactured by: RLC Labs Phoenix, AZ 85034

by RLC Labs Inc.

Reason: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Published: September 23, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

WP Thyroid, Westhroid Pure, 1.75 Grain (113.75 mg) Thyroid USP, packaged in a) 1,000 Tablets, NDC 64727-6150-2 ; b) 30 Tablets, NDC 64727-6150-4; c) 60 Tablets, NDC 64727-6150-5; d) 90 Tablets, NDC 64727-6150-6; e) 100 Tablets, NDC 64727-6150-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034

by RLC Labs Inc.

Reason: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Published: September 23, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

WP Thyroid, Westhroid Pure, 1.5 Grain (97.5 mg) Thyroid USP packaged in a) 1,000 Tablets, NDC 64727-5850-2 ; b) 30 Tablets, NDC 64727-5850-4; c) 60 Tablets, NDC 64727-5850-5; d) 90 Tablets, NDC 64727-5850-6; e) 100 Tablets, NDC 64727-5850-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034

by RLC Labs Inc.

Reason: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Published: September 23, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

WP Thyroid, Westhroid Pure, 1.25 Grain (81.25 mg) Thyroid USP packaged in a) 1,000 Tablets, NDC 64727-6050-2 ; b) 30 Tablets, NDC 64727-6050-4; c) 60 Tablets, NDC 64727-6050-5; d) 90 Tablets, NDC 64727-6050-6; e) 100 Tablets, NDC 64727-6050-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034

by RLC Labs Inc.

Reason: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Published: September 23, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

WP Thyroid, Westhroid Pure, 1 Grain (65 mg) Thyroid USP, packaged in a) 1,000 Tablets, NDC 64727-5750-2 ; b) 30 Tablets, NDC 64727-5750-4; c) 60 Tablets, NDC 64727-5750-5; d) 90 Tablets, NDC 64727-5750-6; e) 100 Tablets, NDC 64727-5750-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034

by RLC Labs Inc.

Reason: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Published: September 23, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

WP Thyroid, Westhroid Pure, 3/4 Grain (48.75 mg) Thyroid USP, packaged in a) 1,000 Tablets, NDC 64727-5650-2 ; b) 30 Tablets, NDC 64727-5650-4; c) 60 Tablets, NDC 64727-5650-5; d) 90 Tablets, NDC 64727-5650-6; e) 100 Tablets, NDC 64727-5650-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034

by RLC Labs Inc.

Reason: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Published: September 23, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

WP Thyroid, Westhroid Pure, 1/2 Grain (32.5 mg) Thyroid USP packaged in a) 1,000 Tablets, NDC 64727-5550-2 ; b) 30 Tablets, NDC 64727-5550-4; c) 60 Tablets, NDC 64727-5550-5; d) 90 Tablets, NDC 64727-5550-6; e) 100 Tablets, NDC 64727-5550-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034

by RLC Labs Inc.

Reason: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Published: September 23, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

WP Thyroid, Westhroid Pure, Thyroid USP, [liothyronine (T3) 2.25 mcg and levothyroxine (T4) 9.5 mcg], 1/4 Grain (16.25 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-5450-4; b) 60-count bottles, NDC 64727-5450-5; c) 90-count bottles, NDC 64727-5450-6; d) 100-count bottles, NDC 64727-5450-1; and e) 1,000-count bottles, NDC 64727-5450-2; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034.

by RLC Labs Inc.

Reason: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Published: September 23, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Nature-Throid, Thyroid USP [liothyronine (T3) 27 mcg and levothyroxine (T4) 114 mcg], 3 Grain (195 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-3312-4; b) 60-count bottles, NDC 64727-3312-5; c) 90-count bottles, NDC 64727-3312-6; d) 100-count bottles, NDC 64727-3312-1; and e) 1,000-count bottles, NDC 64727-3312-2; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034.

by RLC Labs Inc.

Reason: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Published: September 23, 2020
Distribution: Nationwide

View recall →

Data last updated: September 15, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.